| HIPEC Priming Followed by Serplulimab Plus SOX/XELOX in Locally Advanced Gastric Cancer (NCT07621484) | Shanghai Changzheng Hospital | 2026-07-01 |
| KCD (Carfilzomib/Cyclophosphamide/Dexamethasone) Regimen for the Treatment of Newly Diagnosed POEMS Syndrome (NCT07652879) | Shanghai Changzheng Hospital | 2026-06-15 |
| The Effect of Radiotherapy After Separation Surgery for Spinal Metastases (NCT07527884) | Shanghai Changzheng Hospital | 2026-05-01 |
| Postoperative Neurological Recovery and Risk Factor Analysis in Patients With Paralysis Due to Spinal Metastases (NCT07527728) | Shanghai Changzheng Hospital | 2026-05-01 |
| MTS109 in Patients With Refractory Autoimmune Diseases (NCT07526350) | Shanghai Changzheng Hospital | 2026-03-24 |
| Anlotinib Combined With Sintilimab as First-line Treatment for Advanced Non-liver Metastatic Colorectal Cancer (NCT07398326) | Shanghai Changzheng Hospital | 2026-02-24 |
| A Study on the Correlation Between Tear Iron Levels and the Severity of Dry Eye Disease. (NCT07363824) | Shanghai Changzheng Hospital | 2026-02-06 |
| Safety and Preliminary Efficacy Evaluation of LC-K76 Plus Anti-PD-1 Therapy in Patients With Metastatic Castration-Resistant Prostate Cancer (mCRPC) (NCT07389187) | Shanghai Changzheng Hospital | 2026-02-01 |
| Safety and Efficacy Evaluation of LC-K76 in Patients With Metastatic Hormone-Sensitive Prostate Cancer (NCT07389174) | Shanghai Changzheng Hospital | 2026-02-01 |
| Eye Tracking Study on Eye Movement Function and Visual Attention Patterns in Patients With Thyroid-Associated Ophthalmopathy (NCT07381413) | Shanghai Changzheng Hospital | 2026-01-31 |
| Efficacy and Safety of Rifaximin-α in Treating MASLD (NCT07381257) | Shanghai Changzheng Hospital | 2026-01-15 |
| Screening, Classification, and Outcome Prediction Ensemble Using Orbital MRI for Thyroid Eye Disease: The TED SCOPE National Multicenter Registry Study (NCT07716397) | Shanghai Changzheng Hospital | 2026-01-01 |
| Application of Quantum Detection-Driven Artificial Intelligence Algorithms for Single-Molecule cfDNA Characterization in the Early Diagnosis of Prostate Cancer (NCT07238959) | Shanghai Changzheng Hospital | 2025-12-01 |
| Observational Study of Sacral Nerve Function After Sacral Tumor Resection (NCT07105644) | Shanghai Changzheng Hospital | 2025-08-01 |
| Cardiovascular-Kidney-Metabolic Syndrome in Shanghai Zicitizens (NCT07043166) | Shanghai Changzheng Hospital | 2025-07-01 |
| Evaluation of the Efficacy and Safety of Absorbable vs Traditional Bone Wax for Facet Fusion After Lumbar Fusion Surgery (NCT07040293) | Shanghai Changzheng Hospital | 2025-07-01 |
| MSC303 Subcutaneous Injection for the Treatment of Immunologic Glomerular Disease. (NCT07000292) | Shanghai Changzheng Hospital | 2025-06-20 |
| A Dose-Expansion Trial of Intravenous HNF4α srRNA for Unresectable or Metastatic Colorectal Cancer (NCT07050394) | Shanghai Changzheng Hospital | 2025-06-10 |
| HiSCs in the Treatment of Rheumatoid Arthritis (NCT06947746) | Shanghai Changzheng Hospital | 2025-05-01 |
| Evaluation of the Efficacy and Safety Observation of IBI311 Treatment in Patients With Inactive TAO (NCT07152392) | Shanghai Changzheng Hospital | 2025-04-15 |
| Efficacy and Safety of Sequential Hormone Therapy and Tetuzumab Therapy in Patients With Moderate to Severe TAO in the Active Stage After Glucocorticoid Treatment. (NCT07152366) | Shanghai Changzheng Hospital | 2025-04-15 |
| The Aim of This Study is to Assess the Efficacy and Safety of Chidamide, Regorafenib in Combination With Iparomlimab and Tuvonralimab for the Treatment of Advanced Colorectal Cancer in Third-line Therapy and Subsequent Lines. (NCT06930118) | Shanghai Changzheng Hospital | 2025-04-10 |
| The Safety and Efficacy of Sequential Hormone Therapy and IBI311 Therapy in Patients With Active Moderate to Severe TAO in the Initial Treatment. (NCT07152340) | Shanghai Changzheng Hospital | 2025-04-10 |
| Efficacy and Safety of LC-Z300-01 on Proteinuria in Diabetic Patients (NCT06686758) | Shanghai Changzheng Hospital | 2025-04-01 |
| A Study on the Changes of Glucose Metabolism and Exocrine Function in Patients With Chronic Pancreatitis (NCT07314489) | Shanghai Changzheng Hospital | 2025-04-01 |
| Clinical Study of Safety and Efficacy of Universal PSMA CAR- T in Refractory CRPC (NCT06895811) | Shanghai Changzheng Hospital | 2025-03-27 |
| Safety and Efficacy Evaluation of Anti IGF-1R Monoclonal Antibody Combined With Anti-PD-1 Monoclonal Antibody in Treatment in Patients With Metastatic Castration-Resistant Prostate Cancer (NCT06866548) | Shanghai Changzheng Hospital | 2025-03-10 |
| Efficacy and Safety of LC-Z300-01 in Chinese With Type 2 Diabetes (NCT06847178) | Shanghai Changzheng Hospital | 2025-03-01 |
| Fecal Microbiota Transplantation for Obese Women With Polyendocrine Metabolic Ovarian Syndrome (NCT07746635) | Shanghai Changzheng Hospital | 2025-02-21 |
| The Characteristics of Blood Glucose Profile and the Changes of Hormones in PPDM-C Population (NCT06826729) | Shanghai Changzheng Hospital | 2025-02-11 |
| Pancreatic Cancer and Diabetes Mellitus (NCT06585072) | Shanghai Changzheng Hospital | 2025-01-03 |
| UCMSCs Combined With Allogeneic Islet Transplantation for the Treatment of Diabetes (NCT06751199) | Shanghai Changzheng Hospital | 2024-12-30 |
| a Study of CT0596 in Relapsed/Refractory Multiple Myeloma and Relapsed/Refractory Plasma Cell Leukemia (NCT06718270) | Shanghai Changzheng Hospital | 2024-12-11 |
| Carvedilol and Alverine in Portal Hypertension (NCT06696248) | Shanghai Changzheng Hospital | 2024-11-15 |
| A Clinical Trial Evaluating the Safety and Efficacy of Intravenous HNF4α SrRNA in Treating Metastatic CRC Patients (NCT06621173) | Shanghai Changzheng Hospital | 2024-11-12 |
| A Clinical Trial Evaluating the Safety and Efficacy of Intravenous HNF4α srRNA in Treating Advanced ICC Patients (NCT06583993) | Shanghai Changzheng Hospital | 2024-11-07 |
| A Clinical Trial Evaluating the Safety and Efficacy of Intravenous CD-801 in Treating Advanced HCC Patients (NCT06418659) | Shanghai Changzheng Hospital | 2024-10-12 |
| The Application of Multimodal Artificial Intelligence Systems in Prostate Cancer Diagnosis and Prognosis Analysis (NCT06589154) | Shanghai Changzheng Hospital | 2024-10-10 |
| Establishment of Multiparametric Prediction Models for Moderate to SevereThyroid Associated Ophthalmopathy (NCT06590220) | Shanghai Changzheng Hospital | 2024-10-09 |
| Endocrine and Exocrine Secretory Function Alterations After Moderately Severe and Severe Acute Pancreatitis (NCT06590935) | Shanghai Changzheng Hospital | 2024-10-08 |
| Anti-CD70-CAR-T Cell Injection for the Treatment of Locally Advanced or Relapsed/Metastatic CD70+ Inoperable Renal Cells (NCT06586658) | Shanghai Changzheng Hospital | 2024-09-06 |
| The Safety and Efficacy of CD-801 in Patients With Advanced Intrahepatic Cholangiocarcinoma (NCT06572189) | Shanghai Changzheng Hospital | 2024-08-28 |
| Efficacy and Safety of Rifaximin in Treating MAFLD (NCT07185932) | Shanghai Changzheng Hospital | 2024-08-10 |
| Inhaled Mesenchymal Stem Cell-Derived Exosomes in the Treatment of Post-Infectious Cough: A Single-Center Randomized Controlled Clinical Trial (NCT07103980) | Shanghai Changzheng Hospital | 2024-07-16 |
| Application of a Novel Model Based on Plasma cfDNA Assay and MRl Imaging in the Detection of Prostate Cancer (NCT06509919) | Shanghai Changzheng Hospital | 2024-07-09 |
| Study of CT071 Injection in High Risk Newly Diagnosed Multiple Myeloma (NCT06407947) | Shanghai Changzheng Hospital | 2024-06-06 |
| CapeOX Combined With Bevacizumab Plus Anti-PD1 Antibody as Neoadjuvant Therapy for Locally Recurrent Colorectal Cancer (NCT06881537) | Shanghai Changzheng Hospital | 2024-06-01 |
| The Efficacy and Safety of Alverine in the Treatment of Portal Hypertension in Patients With Liver Cirrhosis (NCT06470386) | Shanghai Changzheng Hospital | 2024-06-01 |
| The Safety and Efficacy of Alverine in the Treatment of Cirrhotic Portal Hypertension (NCT06473493) | Shanghai Changzheng Hospital | 2024-06-01 |
| UCMSCs Combined With Standard Therapy for the Treatment of Newly Diagnosed Type 1 Diabetes (NCT06407297) | Shanghai Changzheng Hospital | 2024-05-23 |
| Anti-CD19-CD3E-CAR-T Cells in Relapsed/Refractory Autoimmune Disease (NCT06373081) | Shanghai Changzheng Hospital | 2024-04-20 |
| Clinical Study of Safety and Efficacy of Enhanced PSMA CAR- T in Refractory CRPC (NCT06228404) | Shanghai Changzheng Hospital | 2024-03-03 |
| A Study of Surufatinib Combined With Serplulimab in the Treatment of Advanced Solid Tumors With Neuroendocrine Differentiation That Failed Standard Therapy (NCT06156332) | Shanghai Changzheng Hospital | 2024-01-28 |
| Extraperitoneal SINgle-port rObotic-assisted Radical Prostatectomy (RARP) Versus Transperitoneal Multi-port RARP in the Treatment Of Prostate Cancer (SINO-TOP) (NCT06238713) | Shanghai Changzheng Hospital | 2024-01-08 |
| Intraoperative Radiotherapy in Treating Spinal Metastases (NCT06093854) | Shanghai Changzheng Hospital | 2024-01-01 |
| Oral Prednisone in Treating LCH of Bone in Childhood and Adolescence (NCT06078969) | Shanghai Changzheng Hospital | 2023-11-04 |
| The Effect of Transcutaneous Electrical Acustimulation on Small Bowel Preparation for Capsule Endoscopy (NCT06099392) | Shanghai Changzheng Hospital | 2023-11-01 |
| A Clinical Trial for the Safety and Efficacy of CD-801 in Patients With Advanced Hepatocellular Carcinoma (NCT06092112) | Shanghai Changzheng Hospital | 2023-10-13 |
| Utility of the Clamping Bean Test (CBT) for Covert Hepatic Encephalopathy Screening (NCT06367127) | Shanghai Changzheng Hospital | 2023-10-09 |
| The Observation on the Efficacy of Dual Therapy Based on Vonoprazan in Eradicating Helicobacter Pylori (NCT06004401) | Shanghai Changzheng Hospital | 2023-08-20 |
| A Phase 2 Clinical Trial to Evaluate Zanubrutinib Combined With BR (Bendamustine/Rituximab) Regimen in Subjects With Newly-diagnosed Waldenström's Macroglobulinemia (NCT05979948) | Shanghai Changzheng Hospital | 2023-08-01 |
| CapeOX Combined With Bevacizumab Plus Anti-PD1 Antibody as Neoadjuvant Therapy for Microsatellite Stable Locally Advanced Rectal Cancer (NCT05585814) | Shanghai Changzheng Hospital | 2023-05-01 |
| Study of CT071 Injection in RRMM or PPCL (NCT05838131) | Shanghai Changzheng Hospital | 2023-04-28 |
| Treating Donors With Intravenous Immunoglobulin to Reduce Donor-Derived Infections (NCT05799716) | Shanghai Changzheng Hospital | 2023-04-01 |
| mNGS for Therapy of Urinary Infectious Diseases (NCT05624476) | Shanghai Changzheng Hospital | 2023-01-01 |
| The Instant Efficacy and Safety of Alverine in Decreasing Portal Hypertension: an Exploratory Pilot Study (NCT05508633) | Shanghai Changzheng Hospital | 2022-10-28 |
| Preoperative Nivolumab Plus Bevacizumab Combined With Chemotherapy Before Surgery in Patients With pMMR/MSS Colorectal Cancer Liver Metastases (NCT05588297) | Shanghai Changzheng Hospital | 2022-10-01 |
| BCMA-targeted LCAR-BCDR Cells in Patients With Relapsed/Refractory Multiple Myeloma (NCT05376345) | Shanghai Changzheng Hospital | 2022-09-01 |
| TNFα Monoclonal Antibody for Acute Spinal Cord Injury (NCT04988425) | Shanghai Changzheng Hospital | 2022-09-01 |
| Study of Dual Targeted CD19/BCMA FASTCART GC012F in Relapsed/ Refractory Multiple Myeloma (NCT05412329) | Shanghai Changzheng Hospital | 2022-06-13 |
| Acute Hypertensive Cerebral Hemmorrhage Surgery (NCT04957849) | Shanghai Changzheng Hospital | 2022-01-01 |
| BCMA and CD19 Targeted Fast Dual CART for Chromosomal Abnomalities High-risk BCMA+ Multiple Myeloma (NCT04617704) | Shanghai Changzheng Hospital | 2021-12-01 |
| Effects of Denosumab on Bone Fusion in Osteoporotic Patients After Lumbar Fusion (NCT05203588) | Shanghai Changzheng Hospital | 2021-10-09 |
| Allogeneic Regenerative Islet Transplantation for the Treatment of Brittle Type 1 Diabetes Mellitus (NCT06196996) | Shanghai Changzheng Hospital | 2021-09-14 |
| Multi-centre Study to Evaluate ACAF Versus Laminoplasty in Treating Cervical Ossification of the Posterior Longitudinal Ligament (NCT04968028) | Shanghai Changzheng Hospital | 2021-08-17 |
| Study of FasT CAR-T GC012F Injection in High Risk TE NDMM Patients (NCT04935580) | Shanghai Changzheng Hospital | 2021-06-28 |
| Arsenic Trioxide for Structural p53 Mutations (NCT04695223) | Shanghai Changzheng Hospital | 2021-01-01 |
| Autologous Bone Marrow-derived Mononuclear Cells for Acute Spinal Cord Injury (NCT04528550) | Shanghai Changzheng Hospital | 2020-10-01 |
| Quantitative Assessment of Lumbar Facet Joint Degeneration, A Retrospective Study. (NCT06786611) | Shanghai Changzheng Hospital | 2020-09-01 |
| Anlotinib Plus Sintilimab as First-line Treatment for Patients With Advanced Colorectal Cancer (APICAL-CRC) (NCT04271813) | Shanghai Changzheng Hospital | 2020-06-01 |
| Anlotinib Plus Toripalimab as First-line Treatment for Advanced Gastric Cancer With ECOG 2 (APICAL-GC) (NCT04278222) | Shanghai Changzheng Hospital | 2020-02-10 |
| BCMA and CD19 Targeted Fast Dual CAR-T for BCMA+ Refractory/Relapsed Multiple Myeloma (NCT04236011) | Shanghai Changzheng Hospital | 2020-01-16 |
| Autologous Platelet Rich Plasma on Low Back Pain (NCT02983747) | Shanghai Changzheng Hospital | 2019-11-01 |
| Evaluation of Ultrasensitive Chromosomal Aneuploidy Detection for Detecting Minimal Residual Disease in Multiple Myeloma (NCT04122092) | Shanghai Changzheng Hospital | 2019-10-20 |
| Autologous Regenerative Islet Transplantation for Insulin-dependent Diabetes (NCT05294822) | Shanghai Changzheng Hospital | 2019-09-30 |
| EGFR Monoclonal Antibody for Advanced Gastric Cancer (NCT04136600) | Shanghai Changzheng Hospital | 2019-07-01 |
| Pyrotinib in Combination With Trastuzumab in Treatment-refractory, HER2-positive Metastatic Colorectal Cancar. (NCT03843749) | Shanghai Changzheng Hospital | 2019-07-01 |
| Anlotinib in Advanced Solid Tumors With FGFR Alteration (NCT03929965) | Shanghai Changzheng Hospital | 2019-07-01 |
| Regorafenib Plus PD-1 Inhibitor in Patients With Colorectal Cancer (NCT04110093) | Shanghai Changzheng Hospital | 2019-03-01 |
| ALK Inhibitor in Metastatic Colorectal Cancer With ALK Mutation. (NCT03792568) | Shanghai Changzheng Hospital | 2019-03-01 |
| High-dose FOLFIRI in Advanced Colorectal Cancer Patients With Wild-type UGT1A1*6 and *28 (NCT03329183) | Shanghai Changzheng Hospital | 2019-03-01 |
| Cetuximab and Vemurafenib Plus FOLFIRI for BRAF V600E Mutated Advanced Colorectal Cancer (IMPROVEMENT) (NCT03727763) | Shanghai Changzheng Hospital | 2018-10-08 |
| Computed Tomography Screening for Early Lung Cancer, COPD and Cardiovascular Disease in Shanghai, China (NCT03988322) | Shanghai Changzheng Hospital | 2018-09-01 |
| A Multi-center Study：Comparison of ACAF and ACCF in the Treatment of Cervical OPLL (NCT03591692) | Shanghai Changzheng Hospital | 2018-01-01 |